Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smell Retraining and Budesonide for Post-COVID Smell Loss in Children
NCT04964414Phase 2Terminated
- Start
- Sep 2021
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of budesonide in anosmia and dysosmia. Primary endpoint: University of Pennsylvania Smell Identification Test. Started Sep 2021; status: terminated.
02
Drugs
budesonide
03
Conditions
anosmiadysosmia
Beyond the preview
Go deeper on NCT04964414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04964414.